Learn - January 03, 2021
Who can get vaccinated?
At present, the vaccination strategy is to implement vaccination nationwide according to the "two-step" plan.
The first step is to vaccinate some key populations, including those who are engaged in import cold chain, port quarantine, ship pilotage, aviation aircrew, fresh market, public transportation, medical disease control, etc., and those who go to work or study in medium and high risk countries or regions.
In the second step, more vaccines will be put into use as the vaccines are conditionally approved for marketing or the production of vaccines is gradually increased. By carrying out vaccination in an orderly manner, all eligible people can achieve "all answers".
Where to get vaccinated?
1. Vaccination units are all health service centers, township hospitals or general hospitals located in the jurisdiction. All localities will promptly announce the vaccination sites and units that can be vaccinated within their respective jurisdictions, including locations and service hours.
2. If the vaccination involves concentrated units, some temporary vaccination points will be set up to provide door-to-door services.
3. You can consult the local health administrative department or the disease prevention and control institution in your jurisdiction and pay attention to the relevant information release platform.
4. Reminder: Be sure to follow the arrangement and reminder of local notice, such as carrying ID card, taking personal protection, and providing physical condition voluntarily.
How's the price?
The final pricing is based on cost. The price of this vaccine will change with the expansion of production scale and use scale, and a corresponding price mechanism will be formed after the vaccine is approved for conditional listing.
When can the general public start vaccination?
After the outbreak of COVID-19, China laid out five technical routes to promote vaccine research and development. Up to now, according to the statistics of the World Health Organization, our vaccines entering clinical trials and phase III clinical trials are in the first phalanx in the world. Because China has done a good job in epidemic prevention and control, and China does not have the conditions for conducting Phase III clinical trials, our five vaccines entering Phase III clinical trials are all conducted in foreign countries. The countries and regions with which we cooperate in Phase III clinical trials are not or most of them are not countries and regions with the highest global epidemic situation, so the speed of obtaining the cases required for Phase III clinical trials is naturally not the fastest, which is also in line with scientific laws. As far as the current situation is concerned, the vaccine that we are walking fast has already obtained the number of cases needed in the mid-term of Phase III clinical trials, and has been rolling to provide relevant materials to the State Food and Drug Administration recently.
After the data is exposed, the relevant data will be released to the public in time,If the data meet the corresponding standards, the State Drug Administration will approve the conditional listing or listing, and our vaccine will be popularized and the yield will be increased faster, because we are ready for large-scale production.
Will there be adverse reactions?
Common adverse reactions mainly include: headache and fever, local redness or lumps at the inoculation site, and some people have common adverse reactions such as cough, loss of appetite, vomiting and diarrhea.
What about adverse reactions?
1. Vaccination units and medical personnel involved in medical treatment will receive technical training, and they can only take up their posts after passing the training,Common adverse reactions can be quickly identified and dealt with.
2. The secondary hospital will be responsible for the medical security work of several inoculation units in the area of responsibility, send experienced emergency personnel, carry necessary rescue equipment and medicines, and provide stagnation protection at the inoculation point, so as to deal with the situation in time.
3. Reminder: According to past experience, adverse reactions often occur within 30 minutes after vaccination. All vaccinators should stay at the inoculation point for 30 minutes after inoculation. After 30 minutes, there is no problem to go home. After returning home, symptoms related to adverse reactions appeared, so you should seek medical treatment in time.
Will serious adverse reactions be compensated?
In fact, the identification and compensation of rare serious adverse reactions caused by vaccination in China has formed a relatively perfect management mechanism and system. If serious adverse reactions occur in vaccination work in COVID-19 this time, all localities will deal with them according to the relevant principles already in place.
How long is it valid?
1. It's less than a year since the virus was discovered, so it's too early to tell how long this vaccine can protect, and we can't draw this conclusion yet.
2. At present, the evidence suggests that the vaccine protection period, which is required by WHO for more than half a year, is basically beyond doubt.
Do you need to get one dozen a year like flu vaccine?
1. Influenza vaccines need to be adjusted at any time because of the variation of viruses and different subtypes prevalent every year.
2. It should be said that COVID-19 vaccine does not exist for half a year or needs to be vaccinated again once a year,It is unlikely to be optimistic.
3. Reminder: After being vaccinated with COVID-19 vaccine, everyone is required to continue to maintain personal protective measures, including wearing masks, keeping social distance and washing hands frequently. So far, no vaccine has said that the protection rate is 100%.
Is the virus mutated? Does it affect the vaccine effect?
1. The current research results show that the variation of this virus is within a normal range, and it has no influence on the vaccine effect.
2. Whether there will be great variation in the later stage of the virus, whether it is from the World Health Organization, relevant institutions in various countries, or vaccine enterprises, will continue to pay attention and continue to study.
Workers who are engaged in import cold chain, port quarantine, ship pilotage, aviation air service, fresh market, public transportation, medical disease control and other high infection risks are given priority to vaccination ......
The State Council announced that the national COVID-19 vaccination program was released
On December 19th, the joint prevention and control mechanism of the State Council held a press conference to introduce the vaccination work of key populations in SARS-CoV-2 .
According to Ceng Yixin, head of the vaccine research and development class of the research group of the joint defense and control mechanism of the State Council and deputy director of the National Health and Health Commission, an effective vaccine is the most powerful scientific and technological means to prevent viral diseases.
China has carried out research and development based on five technical routes simultaneously, from April 2, when vaccines were approved for Phase I and Phase II clinical trials, to June, when three vaccines were approved for emergency use, to July, when many vaccines were launched for Phase III clinical trials abroad, the overall work progressed smoothly.
At the same time, who can fight the COVID-19 vaccine? When will you call? Where to fight? And other related issues, the State Council gave a unified answer.
01 which key groups will give priority to COVID-19 vaccination?
Ceng Yixin said that COVID-19 vaccination was carried out for some key populations because of their working relationship, and the infection risk was higher than that of other populations, including workers with higher infection risk, such as import cold chain, port quarantine, ship pilotage, aviation aircrew, fresh market, public transportation, medical disease control, and those who went to work or study in medium and high-risk countries or regions, which need to be effectively protected.
In addition, vaccinating some key populations is the first step of vaccination in COVID-19,With the official listing of vaccines in COVID-19 and the gradual improvement of production and supply assurance capabilities, the vaccination work for the elderly, high-risk groups with basic diseases and the follow-up general population will be carried out in a comprehensive and orderly manner,"Our goal is to strive to establish a group immune protection chain through active immunization. "
Vaccination for the above key populations will be carried out in winter and spring in China. In addition, other people who haven't been vaccinated for the time being don't have to worry,At present, they should take personal protection, wear masks in public places, keep social distance and wash their hands frequently,These measures have been proved to be very effective in the early prevention and control of COVID-19 epidemic, including the long-term practice of disease prevention and control, so everyone must take personal protection.
When will the COVID-19 vaccine be vaccinated? Where to get vaccinated?
The joint prevention and control mechanism of the State Council held a press conference to announce:
1,All localities will announce inoculation points and inoculation time in time as required, and you can pay attention to the information released by the local health administrative department or disease prevention and control institution.
2,Temporary inoculation points will also be set up according to the vaccination needs, and door-to-door services will be provided.
3,The inoculation conditions will be strictly regulated.
4,All inoculation sites will provide the certificate of vaccination against COVID-19.
Reminder: You should bring your ID card and register your vaccine!
How long can COVID-19 vaccine provide protection?
Deputy Director of the National Health and Health Commission: There is basically no doubt for more than half a year
Ceng Yixin, head of the vaccine research and development class of the research group of the joint defense and control mechanism of the State Council and deputy director of the National Health and Health Commission, said that since SARS-CoV-2 appeared less than a year ago, it is still inconclusive how long the vaccine can provide protection, but some data show that there is no doubt that the vaccine protection period is more than half a year.
Ceng Yixin said that in the first half of this year, some vaccines in China started Phase I and Phase II clinical trials, and many volunteers participated in them and have been following up. The data showed that the antibodies of these volunteers still existed.
In addition, many medical institutions also follow-up COVID-19 patients discharged from hospital after rehabilitation,The follow-up data of more than 400 discharged patients in Shenzhen Infectious Disease Hospital showed that antibodies still existed in the first discharged patients 10 months later. "These data all show that there is no doubt that the vaccine protection period is more than half a year. However, we can't conclude whether we can guarantee immunization for 5 years, 10 years or even life. "
Zeng Yixin explained why the flu vaccine should be given once a year. Not because it is protected for one year, but because the virus has mutated and different virus subtypes are prevalent. As for the COVID-19 vaccine, it is optimistically estimated that it should not be vaccinated once every six months or one year.
04 Can you stop wearing a mask when you get vaccinated?
National Health and Health Commission: No! Please protect yourself and wear a mask when you are vaccinated.
Since entering the winter, the epidemic situation in China has been sporadic. How do you view the sporadic outbreak in recent days? As the Spring Festival approaches, can people return home for the New Year with peace of mind? On December 17th, Zhang Boli, academician of Chinese Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, gave an answer.
Academician Zhang Boli believes that there have been many sporadic cases in China recently, but once they are found, they can be controlled quickly and rarely spread to three generations, which proves that our experience and practice in epidemic prevention and control are effective.
Academician Zhang Boli reminded that in cold winter, it is still a high-risk period from mid-December this year to the end of January next year, which still needs high vigilance and prevention. In this regard,
Academician Zhang Boli also gave suggestions from three aspects:
First, stick to some effective methods in the past. For example, gathering less, wearing a mask, washing hands frequently and ventilating frequently,Previous experience has proved that these methods are effective in prevention and control,I hope everyone can insist that the situation will be greatly improved when the spring blossoms next year,Therefore, we must be careful in this period.
Second, I hope that all relevant departments can arrange the return vacation time of Spring Festival this year in advance and make plans in advance. People who need to go home for the Spring Festival can arrange early holidays, don't rush to the peak days in Spring Festival travel rush for holidays, and don't go back for the time being if you don't go home, so as to avoid crowding and possible cross-infection problems.
Third, the medical and health departments should be prepared at any time and should not be taken lightly. Fever clinics, isolation wards, and preparations for all kinds of people and things can't be slacked off,Once individual sporadic cases are found, the virus can be blocked at the first time to prevent the virus from developing.
Academician Zhang Boli said that there will be no epidemic like Wuhan at the beginning of this year,You can rest assured that a peaceful and happy Spring Festival will surely be achieved.
With more than ten years of development, VITAIMED has established good cooperation relationship with global medical partners, providing high-quality medical products and services for global medical partners.
+86 139 1863 8349
+86 21 5839 9546
+86 21 5839 9546
HQ Add.: Room 1601 Haibo Bldg.| No.101 Nanmatou Road | Pudong New District Shanghai 200125 China
Manufacturing Facility Add.: No.26 Huashan Middle Road, Changzhou, Jiangsu Province 213022 China
Navigation